New results from researchers at UC San Diego School of Medicine suggest that intermittent fasting could be an effective treatment approach for Alzheimer’s disease. Mice fed on a time-restricted schedule had better memory and less accumulation of amyloid proteins in the brain compared to controls.
American Heart Association honors UC San Diego Health with multiple awards for its commitment to treating patients with heart disease and stroke.
UC San Diego researchers at the Qualcomm Institute will use a $2 million NIH award to purchase a new, non-invasive machine to study the magnetic fields of the human brain. The research has applications in epilepsy, concussions and more.
Creating new technologically advanced sensors, scientists from UC San Diego and Australia have engineered bacteria that detect the presence of tumor DNA in live organisms. Their innovation could pave the way to new biosensors capable of identifying various infections, cancers and other diseases.
Promising preclinical results from UC San Diego show hematopoietic stem cell therapy was effective in rescuing memory loss, neuroinflammation and beta amyloid build-up in a mouse model of Alzheimer’s disease.
University of California San Diego earned $1.76 billion in research funding last fiscal year, a 6 percent increase over the previous year.
La Jolla Light, April 15
U.S. News & World Report, April 9
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
